Dr. Richardson completed the MD-PhD program at Virginia Commonwealth University’s Medical College of Virginia and neurosurgical residency at the University of California, San Francisco. Dr. Richardson's clinical expertise includes awake brain mapping during epilepsy and DBS surgery, robotic-assisted stereotactic surgery, and network surgery approaches to epilepsy, including Responsive Neurostimulation. He was Director of Epilepsy and Movement Disorders Surgery at the University of Pittsburgh Medical Center (UPMC) from 2011-2019, establishing an internationally recognized intraoperative MRI neurosurgery program, encompassing DBS for movement disorders, gene therapy clinical trials for Parkinson’s disease, and laser thermal ablation for epilepsy. Dr. Richardson is an active consultant on several pioneering clinical trials of brain modulation, in the areas of both closed-loop brain stimulation and gene therapy. Dr. Richardson is recognized internationally for his work, having published numerous related papers and book chapters, and frequently speaking at national and international meetings. He is a member of the Executive Board of the American Society for Stereotactic and Functional Neurosurgery.Dr. Richardson also is a neuroscientist who founded the Brain Modulation Lab, which applies a systems neuroscience approach to improving surgical treatments for epilepsy and movement disorders, largely via research using intracranial recording and stimulation.